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Background: Newborn health is a key issue in addressing the survival of children under five years old, particularly in
low and middle income countries, and the evidence base for newborn health interventions continues to evolve. Over
the last decade, maternal and under five-year-old mortality and morbidity rates have been successfully reduced in
Cambodia, but newborn health has lagged behind. Evidence suggests that an important proportion of newborn mortality
both globally and in Cambodia is attributable to infections and sepsis. While initiatives are being implemented to address
some causes of newborn illness (related to pre-term birth and asphyxia), a country-level approach to reducing infections
has not been formulated. The Newborn Infection Control and Care Initiative (NICCI) is a community and health facility
linked intervention to improve health outcomes for newborns.
Methods/Design: The present study applies a cluster randomized trial, using a stepped wedge design, to assess the
impact of a package intervention on newborn health. The intervention components include addressing infection control
in the perinatal period in health facilities, promoting infection prevention and control practices in health center and home
environments, and improving the timeliness of referrals for newborns with suspected infections to appropriate health
facilities, by linking families to the medical system through a network of community based volunteers who will make
home visits to families in the first week of a newborn’s life.
Discussion: The NICCI trial is designed to complement and enhance the Cambodian Ministry of Health strategies and
objectives for maternal and newborn care. Results of the study will help to inform policy and the possible scale-up of
newborn health interventions in the country.
Trial registration: This trial was registered with Clinicaltrials.gov (identifier: NCT02271737) on 5 October 2014.
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While global estimates of newborn mortality have been
declining, it remains an important public health problem
in low income countries, particularly in settings where
under five-year-old and maternal mortality rates have
decreased more rapidly [1, 2]. It is estimated that up to
40 % of global under five-year-old mortality occurs in
the newborn period (during the first 28 days after birth)
[3]. In Cambodia, maternal and under five-year-old mor-
tality rates have been significantly reduced over the last
10 years, falling from 472 per 100,000 live births in 2005
to 206 per 100,000 live births in 2010, and 83 per 1,000
live births in 2005 to 54 per 1,000 live births in 2010, re-
spectively. Newborn mortality, however, has been more
difficult to address at 28 per 1,000 live births and 27 per
1,000 live births in 2005 and 2010 [4, 5].
In order to address the continued newborn mortality
burden, the Cambodian Ministry of Health (MoH), under
the guidance of the Prime Minister, resolved to redouble
efforts to achieve significant progress in reducing newborn
mortality at its Annual Congress in 2011. Attendees at the
Annual Health Congress, including the United States
Agency for International Development (USAID), the
National Reproductive Health Program, and key non-
governmental organizations (NGOs) and United Nations
partners were called upon and agreed to work with the
MoH in reducing high newborn and child mortality rates
in Cambodia. As yet, however, there has been no agreed
national strategy on how best to achieve the called-for
reductions.
The Royal Government of Cambodia prioritized ma-
ternal mortality reduction through a fast track initiative,
and is committed to improving maternal and child
health [6]. While this policy proposes systemic and pro-
grammatic improvements directed at the prevention of
maternal mortality, it lacks specific strategies for new-
born survival in the postnatal period. The persistently
high rate of neonatal mortality in Cambodia may be due,
at least in part, to the targeting of interventions at the
antenatal, delivery, and immediate postpartum periods
in the health care facility. Care coordination between the
health facility and the community has not been strength-
ened sufficiently, and infants often receive either inad-
equate follow-up during the transition from birth facility
to community, or no follow-up at all. A total of 63.6 %
of mothers reported receiving a postnatal visit within the
first four hours after birth, but only 7.4 % were seen by a
health care professional four to 23 hours post-delivery,
and only 11.3 % were seen in the crucial period of one
to two days after the baby was born [5].
A number of trials have been conducted in sub-Saharan
Africa and South Asia [7–10] illustrating the utility of home
visits by community volunteers to reduce newborn mortal-
ity. A recent Cochrane review, on the subject of communitybased intervention packages for reducing maternal and
neonatal morbidity and mortality and improving neonatal
outcomes, found encouraging evidence of the value of
integrating facility care with newborn care in community
settings through a range of interventions delivered via com-
munity health workers [11]. While community-level care is
important, even greater impact may be achieved by simul-
taneously improving treatment of ill newborns at the com-
munity and health facility level, particularly in cases of
infection and sepsis [12]. Improving service delivery for
newborns through hygienic facilities and facilitated referral
may impact the Cambodian development target for child
health.
Currently, clinics follow the Safe Motherhood Clinical
Protocol (SMCP) for health centers, which provides stand-
ard guidelines for health centers on maternal and newborn
care. The SMCP instructs midwives on signs of maternal
infection that should be monitored: fever, discharge, and
upper or lower urinary tract infections.
The Management of Selected Newborn Problems sec-
tion of the SMCP provides guidance to the health center
staff for providing education to mothers on identifying
symptoms and conditions that should prompt the family
to bring their newborn to the health facility. However,
the protocol is not clear on how to treat some of the
noted conditions. For example, parents are advised that
convulsions are a danger sign indicating the infant
should be referred to the health facility, but there is no
guidance for medical providers on how to manage the
newborn with convulsions upon arriving at the health fa-
cility. The SMCP provides guidance on teaching mothers
how to treat some health issues at home, such as treat-
ing local infection using gentian violet for skin infection
or 1 % tetracycline eye ointment for eye infection, but
there is no instruction on what steps to take if there is
no improvement [13]. As a result, clinic staff are not
properly trained to treat the child, and families may be
sent home or resort to the private sector. If home treat-
ment does not work, the newborn is then referred to the
provincial or national hospital for a higher level of care.
Formative research conducted in the setting for this
study, Takeo province, revealed gaps in essential newborn
care practices [14], and barriers to infection prevention and
control [15]. The data from that formative research guided
the intervention design, and contributed to identifying be-
havioral and logistical targets for the intervention package
components.
Setting
Takeo is one of 25 provinces in Cambodia, located in
southern part of the country, with a population of 843,931
(Fig. 1). The province is subdivided into 10 political ad-
ministrative districts and 100 communes. As with other
provinces, the health system includes a provincial hospital
Fig. 1 Map showing location of Takeo Province in Cambodia. The study will be conducted in Takeo Province (highlighted in red), which is south
of the capital city, Phnom Penh, bordering Vietnam
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Takeo, there are five operational districts (health adminis-
trative districts), 73 health centers, three primary referral
hospitals, and one secondary referral hospital [16]. In each
village there are at least two Village Health Support
Groups (VHSGs), which are made up of community
health volunteers.
Methods/Design
The Newborn Infection Control and Care Initiative (NICCI)
is a community and health facility linked intervention to im-
prove health outcomes for newborns. The trial aims to de-
velop and implement a package intervention at the health
center, community, and household levels, designed to im-
prove care practices and care-seeking for newborns. The
intervention will be evaluated through a cluster randomized
trial. The findings of the study will be used to inform
policy and strategies affecting newborns in Cambodia.
Specific objectives
The specific objectives of this trial are as follows:
1. To improve infection control behavior of staff in
selected health centers, and train staff on infectioncontrol messages to be delivered to pregnant and
newly delivered women.
2. To improve referral of sick newborns by VHSG
volunteers and health center staff through:
telephone-based care coordination between health
center staff and VHSG volunteers when newborns
are sent home with mothers; increased recognition
of danger signs; and shorter time between recognition
of danger signs and care-seeking at an appropriate
health facility.
3. To improve knowledge of newborn danger signs and
appropriate referral for sick newborns by mothers
and families of newborn infants.
4. To diagnose the causes of sepsis among infants with
possible sepsis who are hospitalized at Takeo Provincial
Hospital, through blood cultures and appropriate
antibiotic therapy.
Hypotheses
Our first hypothesis is that by delivering a coordinated inter-
vention that combines improved education for health center
midwives, village health care workers, and mothers of new-
borns, along with improved care coordination via an in-
creased number of interactions (points of contact) between
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knowledge of both infection prevention methods and new-
born danger signs among mothers and health care workers,
more rapid case detection of significant newborn illnesses,
and more rapid and appropriate referral of ill newborns in
the intervention areas, as compared with those not yet
receiving the intervention. We also hypothesize that the
common causes of newborn sepsis in Cambodia are differ-
ent from those reported in other regional settings. We will




The primary outcomes for the study are as follows:
1. Percentage of mothers who know at least three
danger signs;
2. Percentage of VHSG volunteers who know six
danger signs;
3. Percentage of families who seek care from an
appropriate facility;
4. Decreased time between onset of suspected danger
signs and referral to appropriate facility;
5. Improved infection prevention behaviors by family,
as measured by the proportion of hand washing
with soap at key events, calculated as a composite
score from the percentage of mothers or caretakers
reporting hand washing at the following key events:
after going to toilet, before touching newborn,
before eating, and after cleaning baby’s bottom;
6. Improved infection prevention and control
behavior among health center staff, as measured
by the proportion of appropriate hand washing
with soap or disinfectant at key points in
provision of care to mothers and newborns,
calculated as a composite score from: percentage
of health center staff reporting hand washing:
before patient contact (when they examine mother
and newborn), before and after aseptic procedure,
after exposure to blood or body fluids, after
patient contact (after removing gloves), and after
touching patient surroundings.
Secondary outcomes (intermediate outcomes)
The secondary outcomes for the study are as follows:
1. Percentage of newborns visited at least once by
VHSG volunteers on or before day seven of life,
2. Percentage of newborns visited at least twice by
VHSG volunteers or before day seven of life,
3. Percentage of VHSG volunteers who can deliver
hygiene messages,4. Percentage of mothers who received messages on
hygiene from health center staff,
5. Percentage of mothers who received messages on
hygiene from VHSG volunteers,
6. Percentage of mothers who received messages on
care-seeking from VHSG volunteers,
7. Percentage of health center staff who know six
danger signs, and
8. Percentage of health center staff who recall hygiene
messages.
Exploratory outcomes
The exploratory outcomes for the study are as follows: all-
cause newborn mortality, and cause- and age-specific new-
born mortality. While our study may not be sufficiently
powered to show reductions in mortality, we anticipate that
if the hypothesis above is sustained with larger populations,
the intervention will be associated with a reduction in all-
cause mortality, and more specifically, in infection-
associated mortality.
Process evaluation
The intervention is likely to reduce the risk of infection,
and improve the timeliness of care-seeking if infection
does occur. By doing so, neonatal morbidity and mortality
would likely be reduced. As this is a package intervention,
the indicators chosen will evaluate different components
to facilitate understanding of how components related to
any change in intervention versus comparison groups. In-
dicators have been selected which best represent the path-
ways to determining the effect of the intervention, and
additional process indicators will further contribute to un-
derstanding the intervention effects and why the interven-
tion was or was not effective. The indicators chosen have
also been used in several other comparable studies of
package interventions aimed at improving newborn sur-
vival at a community level. Reach, coverage and/or deliv-
ery exposure, and fidelity will be evaluated during the
process evaluation.
Primary outcomes
The primary outcomes of the process evaluation are as
follows:
1. Percentage of newborns visited by a VHSG volunteer
within 24 hours of arriving home,
2. Percentage of newborns visited by a VHSG volunteer
on day three of life,
3. Percentage of newborns visited by a VHSG volunteer
on day seven of life,
4. Number of VHSG volunteers trained,
5. Number of health center staff trained,
6. Presence of training materials in VHSG equipment,
and
Var et al. Trials  (2015) 16:257 Page 5 of 77. Presence of training materials in health centers.
Trial design
The health center functions as the unit of allocation, with
health centers randomized to an intervention start date
using a stepped wedge design. The design is principally a
matched one, with before and after comparisons for each
unit of randomization. On the hypothesis that 16 health
centers are recruited, one health center will be assigned to
start each month, and randomization will be stratified in
order to ensure balance across time points. In this design,
all clusters (health centers) receive the intervention in due
course (unidirectional crossover) and, in particular, the
intervention is never removed once it has been imple-
mented, which allows convenience and alleviates ethical
concerns. All cases will be used in the primary analysis,
constituting an intent-to-treat approach. Full study enroll-
ment will be completed at 16 months and duration of par-
ticipation in the intervention will vary based on
randomization assignment, with all clusters enrolled with
a unidirectional approach and participating for the last six
months of the trial.
All health centers in the trial will be included in the
intervention, but will be randomized to one of 16 start
dates. The center-level intervention will be implemented
one stage at a time, progressively over the study period,
until all centers have received the intervention. In addition
to center level, patient-level data will also be collected.
Thus the analysis is divided into center level and patient
level, with the patient-level analysis as the primary out-
come. All live births occurring in the study area will be eli-
gible, and pregnant women in the last trimester will be
recruited from health center catchment areas using the
stepped wedge design, where each area will serve initially
as control and later as intervention. The study will enroll
a target sample size of 1,957 recently delivered women.
Data collection
Informed consent will be sought from all participants
prior to enrollment. The health-center-level baseline data
will be collected from all 16 clusters, by health center co-
ordinators using an environmental assessment checklist,
prior to the start of the intervention. The same tool will
be used throughout intervention implementation and at
the conclusion of activities. World Health Organization
guidelines indicate that a simple checklist to assess infec-
tion prevention control practice, using key indicators, can
provide important information for process monitoring
and evaluation [17]. Individual-level data related to the
outcomes noted above, including primary, secondary, and
exploratory outcomes, will be collected through interview
by VHSG project coordinators during enrollment in the
third trimester of participant’s pregnancy, and on the 14th
and 29th day of newborn life, at the household level.Midwives will provide mothers with a referral form at
the time of discharge of the newborn from the health
center (the day after birth), in case the infant is subse-
quently brought to the hospital for any reason. The form
will alert hospital staff to collect a blood culture on ar-
rival for infants presenting with possible infectious dis-
eases prior to administering antibiotics. Infants under
one month of age presenting to facility with signs of sep-
sis, based on the definitions given by Zaidi et al. [12],
will have blood samples taken for culture and assayed at
Takeo hospital laboratory.
Sample size and power calculation(s)
Using all-cause newborn mortality as the exploratory out-
come and a stepped wedge design for cluster randomized
trials, we would require a total sample size of 1,957, based
on 80 % power, a 5 % significance level, and a 10 % rate of
loss-to-follow-up, to detect a 20 % reduction in neonatal
mortality with a baseline of up to 40 deaths per 1,000 live
births at the provincial level. For this study, health centers
with an expected minimum of 20 births per month will be
included, resulting in a study population of at least 320
per month, or 5,540 participants over one year and five
months. This will allow us to meet more than 80 % power
of the study primary objectives. Secondary analyses will
examine the impact through process indicators based on a
smaller sample. Other intervention phase outcomes with
higher baseline rates than all-cause mortality (incidence of
newborns with specific danger signs and proportion of
newborns with danger signs referred to an appropriate fa-
cility) are hypothesized to demonstrate 20 % or greater
improved outcome in the intervention group, but the lack
of reliable baseline data on these does not allow us to use
them for power calculations.
Analysis plan
The analyses of study data will be performed using the
principle of intention-to-treat for the analysis of ran-
domized controlled trials. The exploratory data analysis
will be performed for all descriptive statistics, such as
means, proportions, variances, and correlation by time
and group. Two group (control and intervention) com-
parison analysis at each time point, across all time points
and within each cluster will be performed. One-way
crossover design analysis methods will be used for
stepped wedge design data, that is, analyses will be per-
formed accounting for potential within-cluster correl-
ation using a random effect model, multilevel model, or
generalized estimating equations. Based on each month
of the study, we will compare the neonatal mortality rate
in those centers that have not yet received the interven-
tion with those in the centers that have. The study
hypothesis will be tested on the significance level of
alpha = 5 % throughout the analysis. All analyses, summaries,
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using SAS software (version 9.1 or higher in a Windows
environment SAS Institute Inc. Cary, North Carolina,
USA). In order to avoid the potential problem of mul-
tiple comparisons related to the primary outcomes we
plan to apply a Bonferroni correction.
Capacity development
From the implementation study, we envisage the follow-
ing capacity development at the provincial level:
1. Through training and supervision, the intervention
health centers will learn a simple approach in
improving newborn care based on their existing
resources, such as infection prevention control
practices, and coordination and follow-up of
newborns with VHSGs.
2. Through training and supervision, VHSGs in the
intervention clusters will be equipped with better
knowledge and effective educational materials for
providing health education on newborn health, and
will understand and be able to help mothers and
families to act faster on newborn referral.
3. Through meetings and updates on the progress of
the study, the management of the Takeo Provincial
Health Department will be informed and understand
the implementation modality of the study.
We envisage the following capacity development at the
national level:
1. The National Maternal and Child Health Center
(NMCHC), whose director is a member of the Study
Advisory Committee, will contribute to the operational
modality of the study through sharing the study’s
annual progress report, informal interaction with the
project staff, and periodic update during NMCHC
sub-technical working group meetings.
2. Stakeholders in-country, such as USAID/Cambodia,
other United Nations agencies, and NGOs such as
Reproductive Health Association of Cambodia
(RHAC), Reproductive and Child Health Alliance
(RACHA), University Research Corporation (URC),
Cooperative for Assistance and Relief Everywhere
(CARE) International, and so forth will be apprised
of intervention progress through participation in the
sub-technical working groups and access to the
study publications.
3. The National Institute of Public Health, through the
management of the study, will be able to further
improve the capacity of the faculty and
administrative staff, for example in research, grant
management and compliance with trial
requirements.Data dissemination plan and knowledge transfer
Research results will be shared with all study stakeholders,
and promptly discussed with the local health center and
village-level participants. Local dissemination meetings with
the study populations will be held, including through pres-
entation of the study during Operational Health District
monthly meeting and during Provincial Technical Working
Group meetings. After the intervention has concluded, a de-
tailed evaluation report of lessons learned will be distributed
to relevant partners, along with any intervention materials
of interest. Policy briefs will be circulated nationally and
internationally to relevant organizations.
Dissemination of study results will also occur at scien-
tific meetings and through publications on the impact of
the intervention on neonatal morbidity and mortality
rates, behavior change, impact on neonatal care in facil-
ities, referral process and follow-up of neonates, impact
on infection control, types of pathogens isolated from
neonates clinically diagnosed with sepsis, process out-
comes, and lessons learned concerning working with
health center providers and VHSG volunteers, supervi-
sion, monitoring, and performance; training on danger
signs; and social or cultural factors effecting response to
specific care recommendations including special care for
low birth weight babies and referrals.
It is anticipated that dissemination will result in im-
proved policies and strategies to reduce newborn mortal-
ity in Cambodia, especially given the central role of the
NMCHC (who determine MNCH national policy) and
NIPH in the conduct of the study. The Study Advisory
Committee will also facilitate dissemination and integra-
tion of translational findings. Study partners at the na-
tional level are committed to translating research findings
into policy and documenting promising intervention prac-
tices for further scale-up. NGO partners supporting other
health centers will also be invited to share the results and
benefit from technical support from the investigators.
Ethical approval
The study has been approved by Federalwide Assurance
(FWA)-certified institutional review boards (IRBs) in
Cambodia and the United States. In Cambodia, the re-
sponsible IRB is IRB00003143 - National Ethics Com-
mittee Health Research IRB #1 under FWA 00017450
National Institute of Public Health. In the United States,
the responsible IRB is IORG0000197 - Tulane University
Medical Center under FWA 00002055 Tulane Univer-
sity, with approval through an Institutional Review
Board Authorization Agreement.
Discussion
This study addresses the need to evaluate newborn health
approaches linking behavior change in the health center
and home environment with improved care-seeking at the
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how infection prevention control, improved linkages be-
tween health centers and community volunteers, and
prompt care-seeking will impact newborn health. The re-
sults of this study will provide data for policy-level actions
on newborn survival in Cambodia, as well as in other set-
tings with similar health outcomes. It will also contribute
to the potential scale-up of a linked model of community-
facility care for newborns.
Trial status
This study is currently in the early stages of implementa-
tion. Recruitment began 19 February 2015.
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